RetinaLyze’s mission is to prevent vision loss. Diabetes is a problem that is advancing around the world and it is estimated that by 2020 there will be over 300 million registered diabetic (type 1 or 2). In addition, by then it is estimated that the number of unregistered diabetics will exceed 250 million. One of the most feared consequences of diabetes is diabetic retinal pathology since it may lead to blindness. It is therefore essential to make an early diagnosis, which is possible through RetinaLyze.